lovastatin has been researched along with Adhesions, Tissue in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arslan, E; Caglayan, K; Halaclar, B; Oz, B; Sipahi, M; Talih, T | 1 |
Babenko, TI; Eliseeva, MY; Kalzhanov, ZhR; Kosmas, IP; Malvasi, A; Mazitova, MI; Medvediev, MV; Mynbaev, OA; Stark, M; Tinelli, A | 1 |
Imai, A; Suzuki, N | 1 |
Aarons, CB; Becker, JM; Cohen, PA; Gower, A; Leeman, SE; Reed, KL; Stucchi, AF | 1 |
Jeekel, J; van der Wal, JB | 1 |
5 other study(ies) available for lovastatin and Adhesions, Tissue
Article | Year |
---|---|
Comparison of lovastatin and hyaluronic acid/carboxymethyl cellulose on experimental created peritoneal adhesion model in rats.
Topics: Analysis of Variance; Animals; Disease Models, Animal; Female; Hyaluronic Acid; Lovastatin; Peritoneal Diseases; Random Allocation; Rats; Rats, Wistar; Tissue Adhesions | 2014 |
A personalized adhesion prevention strategy: E. Arslan, T. Talih, B. Oz, B. Halaclar, K. Caglayan, M. Sipahi, Comparison of lovastatin and hyaluronic acid/carboxymethyl cellulose on experimental created peritoneal adhesion model in rats, Int. J. Surg. 12
Topics: Animals; Female; Hyaluronic Acid; Lovastatin; Peritoneal Diseases; Tissue Adhesions | 2014 |
HMG-CoA reductase inhibitor lovastatin causes reversible cytoskeleton perturbation by RhoA signalling suppression in peritoneal cell line Met5A.
Topics: Actin Cytoskeleton; Cell Line; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Peritoneal Diseases; Plasminogen Inactivators; rhoA GTP-Binding Protein; Signal Transduction; Tissue Adhesions | 2010 |
Statins (HMG-CoA reductase inhibitors) decrease postoperative adhesions by increasing peritoneal fibrinolytic activity.
Topics: Animals; Ascitic Fluid; Cells, Cultured; Disease Models, Animal; Epithelium; Fibrinolysis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Laparotomy; Lovastatin; Male; Peritoneum; Plasminogen Activator Inhibitor 1; Postoperative Complications; Prognosis; Rats; Rats, Wistar; RNA, Messenger; Tissue Adhesions; Tissue Plasminogen Activator | 2007 |
The use of statins in postoperative adhesion prevention.
Topics: Animals; Cells, Cultured; Disease Models, Animal; Epithelium; Fibrinolysis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Laparotomy; Lovastatin; Peritoneum; Postoperative Complications; Rats; Tissue Adhesions; Tissue Plasminogen Activator | 2007 |